文献速递药物不良反应与药物警戒

形似音似药品名称错误:驱动因素与解决方案

The problem of look-alike, sound-alike name errors: Drivers and solutions.
PubMed 文献 · Br J Clin Pharmacol · 2020-04-20

形似或音似(LASA)药品名称可能相互混淆,若未被拦截可伤害患者。LASA错误源于名称的语言学相似性,并因包装、片剂外观、规格、给药途径或适应症相似而加剧。患病率估计为所有处方的0.00003%至0.0022%,近失事件的7%,以及所有用药错误事件的6.2%至14.7%。解决方案针对人员或系统,包括减少给药期间干扰、排版调整(如选择性大写或粗体)、条形码和计算机化医嘱录入。

要点

  • LASA错误可源于名称音似或形似,并因包装、片剂外观、规格、途径或适应症相似而加剧。
  • LASA错误占所有处方的0.00003%至0.0022%,近失事件的7%,用药错误事件的6.2%至14.7%。
  • 解决方案包括减少给药干扰、排版调整(选择性大写或粗体)、条形码和计算机化医嘱录入。

核心结论

  • LASA药品名称错误可能到达患者并造成伤害,需通过针对人员或系统的干预措施来减少。

研究设计与样本

  • 本文为综述,未报告系统检索范围。

主要发现

  • LASA错误源于名称间的语音或拼写相似性,并因包装、片剂外观、规格、给药途径或治疗适应症相似而加剧。
  • LASA错误患病率估计为所有处方的0.00003%至0.0022%,近失事件的7%,以及所有用药错误事件的6.2%至14.7%。

临床怎么用

  • 可减少给药期间的干扰和分心以降低LASA错误风险。
  • 可采用排版调整如选择性大写(Tall Man letters)或粗体、条形码以及计算机化医嘱录入等系统解决方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Look-alike or sound-alike (LASA) medication names may be mistaken for each other, e.g. mercaptamine and mercaptopurine. If an error of this sort is not intercepted, it can reach the patient and may result in harm. LASA errors occur because of shared linguistic properties between names (phonetic or orthographic), and potential for error is compounded by similar packaging, tablet appearance, tablet strength, route of administration or therapeutic indication. Estimates of prevalence range from 0.00003 to 0.0022% of all prescriptions, 7% of near misses, and between 6.2 and 14.7% of all medication error events. Solutions to LASA errors can target people or systems, and include reducing interruptions or distractions during medication administration, typographic tweaks, such as selective capitalization (Tall Man letters) or boldface, barcoding, and computerized physician order entry.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Bryan R, Aronson JK, Williams A, et al. The problem of look-alike, sound-alike name errors: Drivers and solutions. Br J Clin Pharmacol. 2020. PMID: 32198938. doi:10.1111/bcp.14285

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。